Cancer Gene Therapy - Table of Contents alert Volume 23 Issue 9

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 23, Issue 9 (September 2016) In this issue Short Communication Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you tried listening to the Genepod, the podcast from Genetics in Medicine? Hear direct from the experts, wherever you are and on whatever device. Past topics have included: Investigating the lower risk of solid tumors in Down Syndrome New and Old Quandaries in Newborn Screening Time and effort to practice medical genetics: an expanding challenge Listen to the Genepod and expand your genetics knowledge for free Short Communication Top Mesenchymal stem cell: a new horizon in cancer gene therapy M Mohammadi, M R Jaafari, H R Mirzaei and H Mirzaei Cancer Gene Ther 2016 23: 285-286; advance online publication, August 19, 2016; 10.1038/cgt.2016.35 Abstract | Full Text Original Articles Top Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase Yi Xu, Fanzhen Lv, Xunxia Zhu, Yun Wu and Xiaoyong Shen Cancer Gene Ther 2016 23: 287-294; advance online publication, July 22, 2016; 10.1038/cgt.2016.28 Abstract | Full Text Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial–mesenchymal transition-induced angiogenesis OPEN C Li, Q Li, Y Cai, Y He, X Lan, W Wang, J Liu, S Wang, G Zhu, J Fan, Y Zhou and R Sun Cancer Gene Ther 2016 23: 295-302; advance online publication, August 5, 2016; 10.1038/cgt.2016.30 Abstract | Full Text Retargeted adenoviruses for radiation-guided gene delivery OPEN S A Kaliberov, L N Kaliberova, H Yan, V Kapoor and D E Hallahan Cancer Gene Ther 2016 23: 303-314; advance online publication, August 5, 2016; 10.1038/cgt.2016.32 Abstract | Full Text Coinhibition of overexpressed genes in acute myeloid leukemia subtype M2 by gold nanoparticles functionalized with five antisense oligonucleotides and one anti-CD33(+)/CD34(+) aptamer M A Zaimy, A Jebali, B Bazrafshan, S Mehrtashfar, S Shabani, A Tavakoli, S H Hekmatimoghaddam, A Sarli, H Azizi, P Izadi, B Kazemi, A Shojaei, A Abdalaian and J Tavakkoly-Bazzaz Cancer Gene Ther 2016 23: 315-320; advance online publication, August 12, 2016; 10.1038/cgt.2016.33 Abstract | Full Text The inhibition of epidermal growth factor receptor signaling by hexagonal selenium nanoparticles modified by SiRNA L Kamrani Moghaddam, S Ramezani Paschepari, M A Zaimy, A Abdalaian and A Jebali Cancer Gene Ther 2016 23: 321-325; advance online publication, September 9, 2016; 10.1038/cgt.2016.38 Abstract | Full Text Advertisement A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.  Open for submissions Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.